Recall Enforment Report D-0074-2021

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Zydus Pharmaceuticals (USA) Inc, originally initiated on 10-27-2020 for the product Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-771-77 The product was recalled due to failed dissolution specification. The product was distributed nationwide and the recall is currently terminated.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0074-202110-27-202011-11-2020Class II6,840 unitsLansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-771-77Failed Dissolution SpecificationTerminated
D-0075-202110-27-202011-11-2020Class II7,908 unitsLansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-772-77Failed Dissolution SpecificationTerminated

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
68382-771Lansoprazole LansoprazoleTablet, Orally DisintegratingOralZydus Pharmaceuticals Usa Inc.Human Prescription Drug
68382-772Lansoprazole LansoprazoleTablet, Orally DisintegratingOralZydus Pharmaceuticals Usa Inc.Human Prescription Drug